Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$13.28 - $18.07 $1.44 Million - $1.96 Million
-108,200 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$15.31 - $26.52 $197,759 - $342,558
-12,917 Reduced 10.66%
108,200 $1.75 Million
Q4 2020

Feb 02, 2021

SELL
$16.84 - $27.59 $38,732 - $63,457
-2,300 Reduced 1.86%
121,117 $3.22 Million
Q3 2020

Nov 05, 2020

BUY
$16.2 - $25.7 $335,566 - $532,349
20,714 Added 20.17%
123,417 $2.3 Million
Q2 2020

Aug 12, 2020

BUY
$5.24 - $23.4 $403,495 - $1.8 Million
77,003 Added 299.62%
102,703 $2.4 Million
Q4 2019

Jan 27, 2020

BUY
$1.45 - $6.73 $37,265 - $172,961
25,700 New
25,700 $147,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $198M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.